Biosignatures: Comparative effectiveness research in biomarker clinical studies
Due to increased healthcare expenditure and the need for evidence-supported clinical decision-making, clinical evaluation using comparative effectiveness research (CER) was initially proposed in the US. CER consists of generating and synthesizing evidence in relative benefits, harms, and costs of di...
Main Authors: | Jur-Shan Cheng, David Bin-Shiun Wu, Yu Wen Wen, Pi-Hua Liu, Jr-Rung Lin, Chee-Jen Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-06-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664612001441 |
Similar Items
-
Biosignatures Search in Habitable Planets
by: Riccardo Claudi, et al.
Published: (2019-09-01) -
Biosignatures Associated with Freshwater Microbialites
by: Richard Allen White, et al.
Published: (2020-05-01) -
The Detectability and Constraints of Biosignature Gasses in the Near & Mid-Infrared from Transit Transmission Spectroscopy
Published: (2019) -
A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
by: Bih H. Chendi, et al.
Published: (2021-02-01) -
Morphological Biosignatures in Volcanic Rocks – Applications for Life Detection on Mars
by: Magnus Ivarsson, et al.
Published: (2019-05-01)